HK1004979A1 - Adrenal cortical steroid containing external therapeutic composition for dermatitis. - Google Patents

Adrenal cortical steroid containing external therapeutic composition for dermatitis.

Info

Publication number
HK1004979A1
HK1004979A1 HK98104115A HK98104115A HK1004979A1 HK 1004979 A1 HK1004979 A1 HK 1004979A1 HK 98104115 A HK98104115 A HK 98104115A HK 98104115 A HK98104115 A HK 98104115A HK 1004979 A1 HK1004979 A1 HK 1004979A1
Authority
HK
Hong Kong
Prior art keywords
dermatitis
therapeutic composition
external therapeutic
adrenal cortical
cortical steroid
Prior art date
Application number
HK98104115A
Other languages
English (en)
Inventor
Hajime Yamada
Akira Yamada
Original Assignee
Cac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cac Corp filed Critical Cac Corp
Publication of HK1004979A1 publication Critical patent/HK1004979A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
HK98104115A 1995-12-11 1998-05-13 Adrenal cortical steroid containing external therapeutic composition for dermatitis. HK1004979A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7346006A JP2920611B2 (ja) 1995-12-11 1995-12-11 皮膚炎の治療外用剤

Publications (1)

Publication Number Publication Date
HK1004979A1 true HK1004979A1 (en) 1998-12-18

Family

ID=18380498

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104115A HK1004979A1 (en) 1995-12-11 1998-05-13 Adrenal cortical steroid containing external therapeutic composition for dermatitis.

Country Status (14)

Country Link
US (1) US5885978A (da)
EP (1) EP0780129B1 (da)
JP (1) JP2920611B2 (da)
KR (1) KR0181763B1 (da)
CN (1) CN1153571C (da)
AT (1) ATE290883T1 (da)
AU (1) AU705996B2 (da)
CA (1) CA2173403C (da)
DE (1) DE69634472T2 (da)
DK (1) DK0780129T3 (da)
ES (1) ES2240987T3 (da)
HK (1) HK1004979A1 (da)
SG (1) SG48460A1 (da)
TW (1) TW431889B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
IT1319665B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di corticosteroidi con polimeri polisaccaridici naturali.
EP1216712A1 (en) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
ATE446096T1 (de) 2002-06-03 2009-11-15 Cac Corp Topische präparate zur behandlung von dermatitis
FR2842106B1 (fr) * 2002-07-11 2006-07-14 Centre Nat Rech Scient Dispersions aqueuses de particules nanometriques ou micrometriques pour l'encapsulation de composes chimiques
KR100564153B1 (ko) * 2002-11-28 2006-03-27 주식회사 에이치 엔 비티 아토피성 피부염을 개선시키는 조성물
US8128954B2 (en) 2004-06-07 2012-03-06 California Institute Of Technology Biodegradable drug-polymer delivery system
JP2008501772A (ja) * 2004-06-11 2008-01-24 シンジェンタ リミテッド 炎症性皮膚状態を寛解するための方法
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
JP6313118B2 (ja) * 2014-05-16 2018-04-18 株式会社Cac ＩｇＥ抑制剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231019B2 (da) * 1973-10-16 1977-08-12
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
JPS61246130A (ja) * 1985-04-24 1986-11-01 Japan Fine Chem Kk 水性皮膚及び毛髪化粧料
US4877774A (en) * 1987-09-09 1989-10-31 The United States Of America As Represented By The Department Of Health And Human Services Administration of steroid hormones
DE68901043D1 (de) * 1988-01-14 1992-04-30 Akzo Nv Waessriges pharmazeutisches praeparat.
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
JPH0795311B2 (ja) * 1988-06-30 1995-10-11 日本電気株式会社 二重化処理装置
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
JP2681527B2 (ja) * 1990-02-15 1997-11-26 ジャパンファインケミカル株式会社 細胞活性促進外用剤
GB9012663D0 (en) * 1990-06-07 1990-08-01 Erba Carlo Spa Galenic formulations containing cyclodextrins
JP2578048B2 (ja) * 1992-05-22 1997-02-05 株式会社 シーエーシー 循環瀘過装置
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
JP3535883B2 (ja) * 1993-06-25 2004-06-07 井関農機株式会社 作業機連結装置
JPH0756417A (ja) * 1993-08-09 1995-03-03 Ricoh Co Ltd 回転型現像装置
JP2772619B2 (ja) * 1994-06-28 1998-07-02 株式会社シーエーシー 多糖類水溶液用循環風呂

Also Published As

Publication number Publication date
AU5056096A (en) 1997-06-19
ATE290883T1 (de) 2005-04-15
SG48460A1 (en) 1998-04-17
CA2173403A1 (en) 1997-06-12
CN1153571C (zh) 2004-06-16
EP0780129A3 (en) 2000-07-19
JPH09157171A (ja) 1997-06-17
ES2240987T3 (es) 2005-10-16
KR970032871A (ko) 1997-07-22
US5885978A (en) 1999-03-23
JP2920611B2 (ja) 1999-07-19
CA2173403C (en) 2000-05-16
DK0780129T3 (da) 2005-06-20
TW431889B (en) 2001-05-01
AU705996B2 (en) 1999-06-03
KR0181763B1 (ko) 1999-05-01
CN1151866A (zh) 1997-06-18
EP0780129A2 (en) 1997-06-25
DE69634472D1 (de) 2005-04-21
DE69634472T2 (de) 2006-02-16
EP0780129B1 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
FI961098A0 (fi) Menetelmä progestogeniä ja estrogeniä sisältävän korvikkeen valmistamiseksi
HK1004979A1 (en) Adrenal cortical steroid containing external therapeutic composition for dermatitis.
PL301841A1 (en) Pharmaceutical agent and method of obtaining same
SI0801649T1 (en) Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
IL133585A0 (en) Soluble prodrugs of paclitaxel
HU9200048D0 (en) Process for treating androgene deseases
ZA899671B (en) Phosphinic acid substituted steroids as inhibitors of steroid 5-alpha-reductase
DE69320646T2 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'-halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
ID28160A (id) Sistem pengobatan untuk pemberian fenilasetilglutamina, fenilasetilisoglutamina dan/atau fenilasetat.
Sallis et al. Calcium metabolism in relation to vitamin D and adrenal function in the chick
DE69328635D1 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
NO981282L (no) Calcitriolderivater og deres anvendelser
HUT68239A (en) Process for producing inclusion complexes of nimesulide alkali salts with cyclodextrins or cyclodextrin derivatives and pharmaceutical preparations containing them
AU573262B2 (en) Covalently bound heparin-antithrombin iii complex
UA35566C2 (uk) Лікарський засіб для профілактики і лікування порушень ліпоїдного і холестеринового обміну речовин і спосіб профілактики і лікування цих порушень
IL108155A0 (en) Pharmaceutical compositions containing 17 alphadihydroequilenin or an ester or salt thereof
UA28777A (uk) Спосіб лікування алкогольного делірію, ускладненого набряком-набуханням головного мозку
UA7076A (uk) Спосіб лікування нефротичної форми гломерулонефриту у дітей
UA49572A (uk) Спосіб лікування затяжних пневмоній
UA42908A (uk) Спосіб лікування набутої аутоімунної гемолітичної анемії

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160409